Graziani G - Search Results

1

The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.

Tundo GR, Sbardella D, Santoro AM, Coletta A, Oddone F, Grasso G, Milardi D, Lacal PM, Marini S, Purrello R, Graziani G, Coletta M. Tundo GR, et al. Among authors: graziani g. Pharmacol Ther. 2020 Sep;213:107579. doi: 10.1016/j.pharmthera.2020.107579. Epub 2020 May 19. Pharmacol Ther. 2020. PMID: 32442437 Free PMC article.

2

Triazene compounds induce apoptosis in O6-alkylguanine-DNA alkyltransferase deficient leukemia cell lines.

Tentori L, Graziani G, Gilberti S, Lacal PM, Bonmassar E, D'Atri S. Tentori L, et al. Among authors: graziani g. Leukemia. 1995 Nov;9(11):1888-95. Leukemia. 1995. PMID: 7475280

3

In vitro inactivation of human O6-alkylguanine DNA alkyltransferase by antitumor triazene compounds.

Lacal PM, D'Atri S, Orlando L, Bonmassar E, Graziani G. Lacal PM, et al. Among authors: graziani g. J Pharmacol Exp Ther. 1996 Oct;279(1):416-22. J Pharmacol Exp Ther. 1996. PMID: 8859021

4

Inhibition of O6-alkylguanine DNA-alkyltransferase or poly(ADP-ribose) polymerase increases susceptibility of leukemic cells to apoptosis induced by temozolomide.

Tentori L, Orlando L, Lacal PM, Benincasa E, Faraoni I, Bonmassar E, D'Atri S, Graziani G. Tentori L, et al. Among authors: graziani g. Mol Pharmacol. 1997 Aug;52(2):249-58. doi: 10.1124/mol.52.2.249. Mol Pharmacol. 1997. PMID: 9271347

5

Role of wild-type p53 on the antineoplastic activity of temozolomide alone or combined with inhibitors of poly(ADP-ribose) polymerase.

Tentori L, Lacal PM, Benincasa E, Franco D, Faraoni I, Bonmassar E, Graziani G. Tentori L, et al. Among authors: graziani g. J Pharmacol Exp Ther. 1998 May;285(2):884-93. J Pharmacol Exp Ther. 1998. PMID: 9580640

6

Involvement of the mismatch repair system in temozolomide-induced apoptosis.

D'Atri S, Tentori L, Lacal PM, Graziani G, Pagani E, Benincasa E, Zambruno G, Bonmassar E, Jiricny J. D'Atri S, et al. Among authors: graziani g. Mol Pharmacol. 1998 Aug;54(2):334-41. doi: 10.1124/mol.54.2.334. Mol Pharmacol. 1998. PMID: 9687575

7

Mutation of the mismatch repair gene hMSH2 and hMSH6 in a human T-cell leukemia line tolerant to methylating agents.

Levati L, Marra G, Lettieri T, D'Atri S, Vernole P, Tentori L, Lacal PM, Pagani E, Bonmassar E, Jiricny J, Graziani G. Levati L, et al. Among authors: graziani g. Genes Chromosomes Cancer. 1998 Oct;23(2):159-66. Genes Chromosomes Cancer. 1998. PMID: 9739019

8

Attenuation of O(6)-methylguanine-DNA methyltransferase activity and mRNA levels by cisplatin and temozolomide in jurkat cells.

D'Atri S, Graziani G, Lacal PM, Nisticò V, Gilberti S, Faraoni I, Watson AJ, Bonmassar E, Margison GP. D'Atri S, et al. Among authors: graziani g. J Pharmacol Exp Ther. 2000 Aug;294(2):664-71. J Pharmacol Exp Ther. 2000. PMID: 10900246

9

Cytotoxic and clastogenic effects of a DNA minor groove binding methyl sulfonate ester in mismatch repair deficient leukemic cells.

Tentori L, Vernole P, Lacal PM, Madaio R, Portarena I, Levati L, Balduzzi A, Turriziani M, Dande P, Gold B, Bonmassar E, Graziani G. Tentori L, et al. Among authors: graziani g. Leukemia. 2000 Aug;14(8):1451-9. doi: 10.1038/sj.leu.2401842. Leukemia. 2000. PMID: 10942242

10

hMSH3 overexpression and cellular response to cytotoxic anticancer agents.

Pepponi R, Graziani G, Falcinelli S, Vernole P, Levati L, Lacal PM, Pagani E, Bonmassar E, Jiricny J, D'Atri S. Pepponi R, et al. Among authors: graziani g. Carcinogenesis. 2001 Aug;22(8):1131-7. doi: 10.1093/carcin/22.8.1131. Carcinogenesis. 2001. PMID: 11470740 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

803 results

Search Page

Filters